Prothrombin complex concentrates : advances in research and clinical applications / Michael S. Firstenberg, editor. [electronic resource]

Externí odkaz: Kolekce e-knih KNAV Registrovani uzivatele: plny text online 5 minut, dalsi pristup na vyzadani. Registered users: full text online 5 minutes, further access on request.

Association Of Prothrombin G20210 Gene Polymorphism And Risk Of Thrombosis In B.Thalassemic Children In Egypt.

Autor: M., Hesham¹, Ali, A. S.¹, Abougabal, Shaimaa Mahmoud¹, Fawzy, Amal² a.fawzy25@yahoo.com, magdy, Hanem²

Publikováno v: Zagazig University Medical Journal. Mar2024, Vol. 30 Issue 2, p513-521. 9p.

Andexanet Alfa versus Four-Factor Prothrombin Complex Concentrate for the Reversal of Factor Xa (FXa) Inhibitor-Associated Intracranial Hemorrhage: A Systematic Review of Retrospective Studies.

Autor: Ferreira, Luan Oliveira¹ (AUTHOR) andresper@hotmail.com, Oldemburg, Ricardo Andres León¹ (AUTHOR) jfilho_monteiro@icloud.com, Leitão Filho, João Monteiro¹ (AUTHOR) victoria.winkler16@gmail.com, Cerveira, Rodrigo Arcoverde^2,3 (AUTHOR) rodrigo.arcoverdi@gmail.com, Vasconcelos, Victoria Winkler¹ (AUTHOR) giovanaescribano@gmail.com, da Costa, Giovana Escribano¹ (AUTHOR), Rodrigues, Roseny dos Reis^4,5 (AUTHOR) ny_rodrigues@yahoo.com.br, Lopes, Dielly Catrina Favacho⁶ (AUTHOR) dclopes@ufpa.br

Publikováno v: Journal of Clinical Medicine. Jun2024, Vol. 13 Issue 11, p3077. 9p.

Generation of Rapid and High-Quality Serum by Recombinant Prothrombin Activator Ecarin (RAPClot™).

Autor: Zhao, Kong-Nan¹ (AUTHOR) k.zhao@uq.edu.au, Dimeski, Goce^2,3,4 (AUTHOR) j.dejersey@uq.edu.au, Masci, Paul¹ (AUTHOR) jingjing.wang2@uq.net.au, Johnson, Lambro¹ (AUTHOR), Wang, Jingjing¹ (AUTHOR), de Jersey, John³ (AUTHOR), Grant, Michael⁵ (AUTHOR) michael.grant@q-sera.com, Lavin, Martin F.^1,6 (AUTHOR) k.zhao@uq.edu.au

Publikováno v: Biomolecules (2218-273X). Jun2024, Vol. 14 Issue 6, p645. 21p.

Rapid diagnosis of coagulopathies from vitamin K deficiency in a consecutive case cohort evaluated by comparative assessment of factor II by 1-stage assays with prothrombin time vs Ecarin reagents.

Autor: Bourguignon A; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; Division of Hematology and Oncology, Department of Medicine, Université de Montréal, Montréal, Québec, Canada., Mathews N; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; Department of Clinical Laboratory Medicine, OPTILAB Montréal-CHU Sainte-Justine, Hematology/Oncology, Centre Hospitalier Universitaire Sainte-Justine, Montréal, Québec, Canada., Tasneem S; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada., Douketis J; Division of Hematology & Thromboembolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Medicine, St. Joseph's Healthcare, Hamilton, Ontario, Canada., Hayward CPM; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; Division of Hematology & Thromboembolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Hematology, Hamilton Health Sciences, Hamilton, Ontario, Canada; Hematology, Hamilton Regional Laboratory Medicine Program, Hamilton, Ontario, Canada. Electronic address: haywrdc@mcmaster.ca.

Publikováno v: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 Nov; Vol. 22 (11), pp. 3059-3069. Date of Electronic Publication: 2024 Aug 14.